Europe
Rentschler Biopharma SE, announced that Dr. Jesús Zurdo will join the company as Senior Vice President Process Science and Innovation, effective January 01, 2019.
As the holidays approach, the U.S. Food and Drug Administration (FDA) is getting in a few drug approvals to wrap up the year. This week there are two decision dates, with another that has been delayed for several months. Here’s a look.
With the year closing out, biotech and pharma companies are making adjustments to their leadership ranks and boards of directors.
In writing literally hundreds of stories this year, two BioSpace writers, Alex Keown and Mark Terry, found certain stories particularly intriguing or impactful. Some of those were such big topics that they were covered over a series of stories. Looking back at 2018, here are their Top 10.
U.S.-based Merck and Co. has made a deal to acquire French company Antelliq Group for about $2.4 billion. Antelliq is a digital technology company focused on services for veterinarians, farmers and pet owners.
Because many types of prostate cancer are very slow growing and generally diagnosed in older men, so-called “watchful waiting” is often the prescribed treatment plan. Now researchers are saying this may not be the best way.
CARMAT today announces the appointment of Pascale d’Arbonneau as Chief Financial Officer.
Days after Axovant announced an end to focusing on its legacy small molecule portfolio in favor of gene therapies, the company announced it has licensed worldwide rights to two gene therapy programs from the University of Massachusetts School of Medicine.
MorphoSys AG reported today that its licensee Janssen has announced that results from the ECLIPSE study demonstrated that Tremfya(R) (guselkumab) was superior to Cosentyx(R) (secukinumab) in treating adults with moderate to severe plaque psoriasis for the primary endpoint of a PASI 90 response at week 48.
The program has awarded 5 startups in two therapeutic areas, Central Nervous System and Respiratory, with seed investments of up to 100,000 euros and the chance to start a strategic partnership with Zambon
PRESS RELEASES